Evidence map›Paper›PMID 33584094›Full record

ArticleAfrican journal of biomedical research : AJBR2020

Protocol and Researcher's Relationship with Institutional Review Board.

A E Orimadegun

Abstract read
In one paragraph

Article in African journal of biomedical research : AJBR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A E OrimadegunInstitute of Child Health, College of Medicine, University of Ibadan. Ibadan, Nigeria.

Funding

Addressing NCDs in Nigeria through Enhanced International Partnership and Interdisciplinary Research TrainingD71TW010876 · FIC · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI BABALOLA, CHINEDUM PEACE, OJENGBEDE, OLADOSU AKANBI · 2017 to 2017
$49k
FIC NIH HHS D71 TW010876
6 · The paper itself

Abstract

The document of ethical approval is an important official requirement for research involving human participants worldwide. It is the process whereby an investigator submits the full research proposal and related documents including detailed informed consent process to an independent Institutional Review Board (IRB) for scrutiny. The process of seeking review and approval is necessary to ensure adequate measure are in place to safeguard and protect research participants as entrenched in the principles of The Declaration of Helsinki and The Belmont Report. It is the responsibility of every clinical researcher to obtain ethical approval, therefore, their obligation to understand the process of review and establish relationship with local IRB in order to enhance smooth review and approval. This article, therefore, explains clinical research and distinguishes between research and clinical care, clarifies briefly what constitutes a study protocol and describes the researchers' relationship with IRB.

Indexed as

clinical practiceClinical researchethical approvalinstitutional review boardstudy protocol

Identifiers

PMID33584094
PMCPMC7876614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.